Financial Security Advisor, Inc.
Position in GILD — Gilead Sciences, Inc.
CIK 1997602
VIRGINIA BEACH, VA
Position in GILD
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$254,701
-$24,596 QoQ
Shares Held
2,016
+0.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#1,772
of 2,266 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Financial Security Advisor, Inc. holds $17,567,229 across 7 Drug Manufacturers - General names. GILD ranks #7 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
65,060 | $8,360,210 | |
| 2 | JNJ |
Johnson & Johnson
|
21,092 | $5,356,735 | |
| 3 | LLY |
ELI LILLY & Co
|
1,627 | $1,951,472 | |
| 4 | ABBV |
AbbVie Inc.
|
3,178 | $799,711 | |
| 5 | AMGN |
Amgen Inc
|
1,352 | $489,586 | |
| 6 | NVS |
Novartis AG
|
2,264 | $354,814 | |
| 7 | GILD |
Gilead Sciences, Inc.
This page
|
2,016 | $254,701 |
All Filings in GILD
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $254,701 | 2,016 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $279,297 | 2,004 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $249,530 | 2,033 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $224,331 | 2,021 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $219,189 | 1,977 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $220,290 | 1,966 | Shares | Sole | 2025-05-01 | |
| No filing history on record for this holder in this stock. | ||||||